CJ to co-promote Herben, anti-hypertensive product

CJ CheilJedang says it has recently signed an agreement with Mitsubishi Tanabe Pharma Corporation and Welfide Korea to co-market an old-version calcium channel blocker Herben, which was developed by Tanabe Seiyaku and launched in 1981 in Korea.

Under the agreement, CJ will be responsible for production and sales of Herben, while its marketing and wholesaling business will be handled by Welfd...